β1-integrin/hERG1/CXCR4 complex was found to participate in the interaction between MSCs and ALL cells, activating both the ERK1/2 and the phosphoinositide 3-kinase (PI3K)/Akt pathways to promote the survival of leukemic blasts [60]. This evidence concerns the gene MAPK3 and acute lymphoblastic leukemia.